NETEC COVID-19 Webinar Series

COVID-19 Therapeutics

Release Date: 12/16/2020

Expires: 12/15/2021

CID: 49434

The estimated time to complete this enduring material is 75 minutes.

TARGET AUDIENCE

This enduring material is intended primarily for healthcare workers and teams which may include but are not limited to, medical and nursing staff, administration, education/training leadership, and infection control leadership. Staff specializing in emergency management, communications, specialized clinical areas, laboratory, facilities management and environmental services are also welcome.

EDUCATIONAL OBJECTIVES

At the conclusion of this enduring material, the participant should be better able to:

• Discuss current evidence surrounding clinical trials for COVID-19 therapeutics
• Describe the FDA's Coronavirus Treatment Acceleration Program (CTAP) when determining new treatments for COVID that are deemed safe and effective.

REQUIREMENTS FOR SUCCESSFUL COMPLETION

In order to receive CME/CNE credit, you must complete these steps prior to the activity expiration date.

1. View the entire presentation
2. Complete the post-test with a score of 2 out of 3 or better
3. Complete the online evaluation
4. Submit the Completion Attestation

CREDIT